Cargando…
ISG15 Inhibits IFN-α-Resistant Liver Cancer Cell Growth
Hepatocellular carcinoma (HCC) is one of the most prevalent tumors worldwide. Interferon-α (IFN-α) has been widely used in the treatment of HCC, but patients eventually develop resistance. ISG15 ubiquitin-like modifier (ISG15) is a ubiquitin-like protein transcriptionally regulated by IFN-α which sh...
Autores principales: | Wan, Xin-xing, Chen, Han-chun, Khan, Md. Asaduzzaman, Xu, Ai-hua, Yang, Fu-lan, Zhang, Yun-yi, Zhang, Dian-zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762208/ https://www.ncbi.nlm.nih.gov/pubmed/24024201 http://dx.doi.org/10.1155/2013/570909 |
Ejemplares similares
-
IFN-λ4 potently blocks IFN-α signalling by ISG15 and USP18 in hepatitis C virus infection
por: Sung, Pil Soo, et al.
Publicado: (2017) -
ISG15: It's Complicated
por: Dzimianski, John V., et al.
Publicado: (2019) -
Antiviral Properties of ISG15
por: Lenschow, Deborah J.
Publicado: (2010) -
The Antiviral Activities of ISG15
por: Morales, David J., et al.
Publicado: (2013) -
The ISG15 Conjugation System
por: Durfee, Larissa A., et al.
Publicado: (2011)